PACTR202102832069874尚未招募未知
A feasibility CGM trial for patients with type 1 diabetes followed at a rural, first-level hospital in a low-income country
Dexcom0 个研究点目标入组 45 人开始时间: 2021年2月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •a T1D diagnosis
- •enrolled in the NCD program at the mentioned PIH-supported facilities
- •Participant must be greater than or equal to 2 year of age
排除标准
- •inability of subject or care-provider to use transmitter and applicator
研究者
相似试验
进行中（未招募）
1 期
A Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive EpisodeBipolar II DisorderMedDRA version: 26.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-006861-39-NLGH Research Ireland Limited15
招募中
1 期
A Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive EpisodeBipolar II DisorderMedDRA version: 26.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-006861-39-DEGH Research Ireland Limited15
招募中
1 期
A phase 2 clinical trial of GH001 in patients with postpartum depressioEUCTR2021-006879-42-NLGH Research Ireland Limited15
未知
1 期
Phase I Study of GDC-0941JPRN-jRCT2080222116Chugai Pharmaceutical Co., Ltd.19
已完成
2 期
Inhibition of Fructosamine Oxidase in Diabetic Nephropathy (INFO-Renal) StudyACTRN12612000959875Protemix Corporation, Ltd.120